Related Experiment Video
Updated: Jul 29, 2026
06:31
Primary Tumor and MEF Cell Isolation to Study Lung Metastasis
Published on: May 20, 2015
Louisiana Tumor Registry: new developments and activities.
V W Chen1, C N Correa, P A Andrews
1Department of Public Health and Preventive Medicine, Louisiana State University Medical Center, New Orleans, USA.
Summary
The Louisiana Tumor Registry (LTR) has expanded its operations and research capabilities over the last three years. These advancements aim to better understand cancer causes, treatment, and survival, ultimately reducing cancer rates in Louisiana.
Area of Science:
- Public Health
- Cancer Epidemiology
- Biostatistics
Background:
- The Louisiana Tumor Registry (LTR) has undergone significant operational enhancements.
- Recent funding initiatives have broadened the scope of the LTR's activities.
Purpose of the Study:
- To detail recent developments and expanded functions of the LTR.
- To highlight the registry's role in addressing cancer causes, treatment, and survival.
- To underscore the LTR's contribution to reducing cancer morbidity and mortality in Louisiana.
Main Methods:
- Expansion of data collection protocols.
- Involvement in special etiologic studies.
- Participation in research collaborations and special studies.
Main Results:
- Enhanced operational efficiency of the LTR.
- Broadened functional capacity of the registry.
- Increased participation in cancer research initiatives.
Conclusions:
- The LTR's recent developments have strengthened its ability to fulfill its legal mandates.
- Expanded registry activities are crucial for advancing cancer research and control in Louisiana.
- The LTR plays a vital role in reducing the burden of cancer in the state.
More Related Videos
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.